Page 90 - Michael Erman News Today

The U.S. government on Saturday authorized Johnson & Johnson's single-dose COVID-19 vaccine, enabling millions more Americans to be vaccinated in the coming weeks and setting the vaccine up for additional approvals around the world.

Johnson & Johnson is waiting on regulatory approval of a new, larger plant operated by contract manufacturer Catalent Inc to begin large-scale U.S. deliveries of its just-authorized COVID-19 vaccine following initial shipments this week, a top J&J executive said on Monday. J&J will ship nearly 4 million doses of the one-shot vaccine around the United States this week and expects to deliver another 16 million doses later this month. "The first doses come from a smaller plan...

The U.S. government on Saturday authorized Johnson & Johnsons single-dose COVID-19 vaccine, enabling millions more Americans to be vaccinated in the coming weeks and setting the vaccine up for... | March 4, 2021

By Julie Steenhuysen (Reuters) - The U.S. government on Saturday authorized Johnson & Johnson's single-dose COVID-19 vaccine, enabling millions mo...

By Julie Steenhuysen (Reuters) - The U.S. government on Saturday authorized Johnson & Johnson's single-dose COVID-19 vaccine, enabling millions mo...

(Reuters) - The U.S. government on Saturday authorized Johnson & Johnson's single-dose COVID-19 vaccine, e...

By Syndicated Content By Julie Steenhuysen (Reuters) - The U.S. government on Saturday authorized Johnson & Johnsons single-dose COVID-19 vaccine, enabling millions more Americans to be vaccinated in the coming weeks and setting it up for additional approvals around the world. The U.S. Food and Drug Administration announced the emergency use authorization for adults aged 18 and older following Fridays unanimous endorsement by the agencys panel of outside experts. In J&Js 44,000-pers...

By Julie Steenhuysen (Reuters) - The U.S. government on Saturday authorized Johnson & Johnson's single-dose COVID-19 vaccine, enabling millions more A...

* Immune system could turn on the vaccine * Need for repeat shots seen likely as variants evolve * UK government aware of vector immunity issue ZURICH, Feb 26 (Reuters) - Vaccines from AstraZeneca , Russia’s Gamaleya Institute and Johnson & Johnson fight the coronavirus with another virus, leaving scientists concerned the shots may lose potency if annual inoculations become necessary to fight new variants. So-called viral vector shots - also used by several Chinese COVID-19 vaccine developers...

U.S. regulators on Friday said they would work quickly to authorize Johnson & Johnson's COVID-19 vaccine for emergency use after a panel of outside advisers backed the one-shot immunization.